These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 15129579

  • 21. [Estrogens and cardiovascular diseases: should current guidelines be changed?].
    Beller F, Theiss W.
    Zentralbl Gynakol; 1994; 116(8):441-8. PubMed ID: 7941812
    [Abstract] [Full Text] [Related]

  • 22. Are some types of hormone therapy safer than others? Lessons from the Estrogen and Thromboembolism Risk study.
    Rexrode KM, Manson JE.
    Circulation; 2007 Feb 20; 115(7):820-2. PubMed ID: 17309929
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Contraception in risk patients. Discussion].
    Detering K, Hartmann E.
    Med Welt; 1980 Dec 05; 31(49):1805-6. PubMed ID: 7207122
    [No Abstract] [Full Text] [Related]

  • 26. [Summary of the practice guideline 'Hormonal contraception' (second revision) from the Dutch College of General Practitioners].
    Siemons GH.
    Ned Tijdschr Geneeskd; 2004 Oct 02; 148(40):1999. PubMed ID: 15524140
    [No Abstract] [Full Text] [Related]

  • 27. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F, Duchemin J, Leroyer C, Delahousse B, Abgrall JF, Mottier D, Groupe d'Etude de la Thrombose de Bretagne Occidentale (G.E.T.B.O).
    Thromb Haemost; 2008 Jan 02; 99(1):223-8. PubMed ID: 18217158
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Estrogen and thromboembolic disorders: should patients stop hormones prior to cosmetic surgery?
    Shiffman MA.
    J Womens Health (Larchmt); 2003 Nov 02; 12(9):853-5; discussion 855. PubMed ID: 14670164
    [Abstract] [Full Text] [Related]

  • 33. Postmenopausal hormone therapy and cardiovascular disease: an overview of main findings.
    Canonico M, Straczek C, Oger E, Plu-Bureau G, Scarabin PY.
    Maturitas; 2006 Jul 20; 54(4):372-9. PubMed ID: 16730142
    [Abstract] [Full Text] [Related]

  • 34. Oral steroid contraception.
    Sech LA, Mishell DR.
    Womens Health (Lond); 2015 Nov 20; 11(6):743-8. PubMed ID: 26673988
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Hormonal contraception--thromboembolic disorders and surgical risk (author's transl)].
    Göretzlehner G, Frick G, Frick U.
    Zentralbl Chir; 1976 Nov 20; 101(18):1103-11. PubMed ID: 983453
    [Abstract] [Full Text] [Related]

  • 40. Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland.
    Korhonen K, Raitanen J, Isola J, Haapasalo H, Salminen T, Auvinen A.
    Cancer Causes Control; 2010 Dec 20; 21(12):2149-56. PubMed ID: 20730482
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.